Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "KEYNOTE"

78 News Found

Piyush Goyal invites Oman to increase pharma trade with India
News | May 13, 2022

Piyush Goyal invites Oman to increase pharma trade with India

The pharma companies will bring quality products at competitive prices to consumers in Oman and help bring down the cost of healthcare


Merck’s Keytruda approved for fourth gynecologic cancer indication
Drug Approval | March 22, 2022

Merck’s Keytruda approved for fourth gynecologic cancer indication

The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial


Japan tops CPhI ‘API Quality’ ranking for second year
News | March 13, 2022

Japan tops CPhI ‘API Quality’ ranking for second year

Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers


Merck’s KEYTRUDA demonstrates extended relief for patients with resected stage IIB and IIC melanoma
Biotech | March 08, 2022

Merck’s KEYTRUDA demonstrates extended relief for patients with resected stage IIB and IIC melanoma

New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients


European Commission approves Merck’s KEYTRUDA as adjuvant therapy for RCC
Drug Approval | January 28, 2022

European Commission approves Merck’s KEYTRUDA as adjuvant therapy for RCC

KEYTRUDA is now approved as monotherapy for adults with Renal Cell Carcinoma (RCC)


Merck’s KEYTRUDA shows promise as adjuvant treatment for non-small cell lung cancer
Biotech | January 11, 2022

Merck’s KEYTRUDA shows promise as adjuvant treatment for non-small cell lung cancer

First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC


Medical institutes urge action on Front-of-Pack labels (FOPL) to address India’s health crisis
Public Health | September 14, 2021

Medical institutes urge action on Front-of-Pack labels (FOPL) to address India’s health crisis

Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor


Merck’s KEYTRUDA receives China approval for Esophageal cancer
Drug Approval | September 09, 2021

Merck’s KEYTRUDA receives China approval for Esophageal cancer

The medicine is now approved for eight indications across five different types of cancer in China.